TNFα has been shown to act directly upon adipocytes and altered levels have been suggested to interfere with glycaemic homeostasis and promote greater insulin resistance [47] as well as promoting endothelial dysfunction by inducing NF-κB signalling, NADPH activation and ROS production [48, 49]. The gene discussed is NFKB1; the disease is Insulin resistance.